nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—myometrium—sarcoma	0.0289	0.118	CbGeAlD
Cysteamine—SST—embryo—sarcoma	0.0278	0.114	CbGeAlD
Cysteamine—SST—hematopoietic system—sarcoma	0.0248	0.102	CbGeAlD
Cysteamine—SST—connective tissue—sarcoma	0.0239	0.0978	CbGeAlD
Cysteamine—SST—smooth muscle tissue—sarcoma	0.0218	0.0895	CbGeAlD
Cysteamine—MPO—endothelium—sarcoma	0.0203	0.0833	CbGeAlD
Cysteamine—SST—lymphoid tissue—sarcoma	0.0175	0.0715	CbGeAlD
Cysteamine—SST—liver—sarcoma	0.0128	0.0526	CbGeAlD
Cysteamine—NPY2R—Peptide GPCRs—CXCR4—sarcoma	0.0127	0.0702	CbGpPWpGaD
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—CREB1—sarcoma	0.0101	0.0554	CbGpPWpGaD
Cysteamine—MPO—hematopoietic system—sarcoma	0.00998	0.0409	CbGeAlD
Cysteamine—SST—lymph node—sarcoma	0.00985	0.0404	CbGeAlD
Cysteamine—MPO—connective tissue—sarcoma	0.00961	0.0394	CbGeAlD
Cysteamine—MPO—skin of body—sarcoma	0.00868	0.0356	CbGeAlD
Cysteamine—MPO—Vitamin B12 Metabolism—HBA1—sarcoma	0.00868	0.0478	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—HBA1—sarcoma	0.00706	0.0389	CbGpPWpGaD
Cysteamine—MPO—lymphoid tissue—sarcoma	0.00703	0.0288	CbGeAlD
Cysteamine—MPO—C-MYB transcription factor network—CD34—sarcoma	0.00703	0.0387	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—MYOD1—sarcoma	0.00703	0.0387	CbGpPWpGaD
Cysteamine—MPO—bone marrow—sarcoma	0.0064	0.0262	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—CXCR4—sarcoma	0.00624	0.0344	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCR4—sarcoma	0.00599	0.033	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—HBA1—sarcoma	0.00561	0.0309	CbGpPWpGaD
Cysteamine—MPO—testis—sarcoma	0.00547	0.0224	CbGeAlD
Cysteamine—SST—G alpha (i) signalling events—CXCR4—sarcoma	0.00527	0.029	CbGpPWpGaD
Cysteamine—MPO—liver—sarcoma	0.00517	0.0212	CbGeAlD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCR4—sarcoma	0.00505	0.0278	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.00469	0.0258	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00419	0.0231	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00402	0.0221	CbGpPWpGaD
Cysteamine—MPO—lymph node—sarcoma	0.00397	0.0163	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—CREB1—sarcoma	0.00392	0.0216	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL2—sarcoma	0.00364	0.0201	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCR4—sarcoma	0.00319	0.0176	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—CREB1—sarcoma	0.00307	0.0169	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCR4—sarcoma	0.00306	0.0169	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Vincristine—sarcoma	0.00302	0.00526	CcSEcCtD
Cysteamine—Connective tissue disorder—Vincristine—sarcoma	0.00301	0.00523	CcSEcCtD
Cysteamine—Malnutrition—Thiotepa—sarcoma	0.003	0.00523	CcSEcCtD
Cysteamine—Erythema—Thiotepa—sarcoma	0.003	0.00523	CcSEcCtD
Cysteamine—Urethral disorder—Vincristine—sarcoma	0.003	0.00522	CcSEcCtD
Cysteamine—Erythema—Dactinomycin—sarcoma	0.00298	0.00519	CcSEcCtD
Cysteamine—Tension—Thiotepa—sarcoma	0.00295	0.00513	CcSEcCtD
Cysteamine—Nervousness—Thiotepa—sarcoma	0.00292	0.00508	CcSEcCtD
Cysteamine—Bone disorder—Doxorubicin—sarcoma	0.00283	0.00493	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—JUN—sarcoma	0.00282	0.0155	CbGpPWpGaD
Cysteamine—Thinking abnormal—Doxorubicin—sarcoma	0.0028	0.00487	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.00279	0.0154	CbGpPWpGaD
Cysteamine—Anaemia—Thiotepa—sarcoma	0.00278	0.00483	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Epirubicin—sarcoma	0.00277	0.00481	CcSEcCtD
Cysteamine—Agitation—Thiotepa—sarcoma	0.00276	0.0048	CcSEcCtD
Cysteamine—Anaemia—Dactinomycin—sarcoma	0.00276	0.0048	CcSEcCtD
Cysteamine—Renal failure—Etoposide—sarcoma	0.00271	0.00472	CcSEcCtD
Cysteamine—Leukopenia—Thiotepa—sarcoma	0.00269	0.00468	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—KIT—sarcoma	0.00269	0.0148	CbGpPWpGaD
Cysteamine—Mental disorder—Vincristine—sarcoma	0.00268	0.00466	CcSEcCtD
Cysteamine—Leukopenia—Dactinomycin—sarcoma	0.00267	0.00464	CcSEcCtD
Cysteamine—Convulsion—Thiotepa—sarcoma	0.0026	0.00453	CcSEcCtD
Cysteamine—Erythema—Mitoxantrone—sarcoma	0.00259	0.00451	CcSEcCtD
Cysteamine—Hypertension—Thiotepa—sarcoma	0.00259	0.00451	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.00256	0.00446	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00254	0.00442	CcSEcCtD
Cysteamine—Discomfort—Dactinomycin—sarcoma	0.00251	0.00436	CcSEcCtD
Cysteamine—Confusional state—Thiotepa—sarcoma	0.00247	0.0043	CcSEcCtD
Cysteamine—Anaemia—Vincristine—sarcoma	0.00246	0.00428	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.00246	0.0136	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Etoposide—sarcoma	0.00245	0.00426	CcSEcCtD
Cysteamine—Agitation—Vincristine—sarcoma	0.00245	0.00426	CcSEcCtD
Cysteamine—Urethral disorder—Etoposide—sarcoma	0.00243	0.00423	CcSEcCtD
Cysteamine—Nervous system disorder—Thiotepa—sarcoma	0.0024	0.00418	CcSEcCtD
Cysteamine—Mental disability—Epirubicin—sarcoma	0.0024	0.00418	CcSEcCtD
Cysteamine—Anaemia—Mitoxantrone—sarcoma	0.0024	0.00417	CcSEcCtD
Cysteamine—Leukopenia—Vincristine—sarcoma	0.00238	0.00415	CcSEcCtD
Cysteamine—Skin disorder—Thiotepa—sarcoma	0.00238	0.00414	CcSEcCtD
Cysteamine—Anorexia—Thiotepa—sarcoma	0.00234	0.00407	CcSEcCtD
Cysteamine—Leukopenia—Mitoxantrone—sarcoma	0.00232	0.00404	CcSEcCtD
Cysteamine—Anorexia—Dactinomycin—sarcoma	0.00232	0.00404	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.00231	0.00402	CcSEcCtD
Cysteamine—Convulsion—Vincristine—sarcoma	0.00231	0.00402	CcSEcCtD
Cysteamine—Hypertension—Vincristine—sarcoma	0.0023	0.004	CcSEcCtD
Cysteamine—Hepatic function abnormal—Epirubicin—sarcoma	0.0023	0.004	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL2—sarcoma	0.00229	0.0126	CbGpPWpGaD
Cysteamine—Convulsion—Mitoxantrone—sarcoma	0.00225	0.00391	CcSEcCtD
Cysteamine—Hypertension—Mitoxantrone—sarcoma	0.00224	0.0039	CcSEcCtD
Cysteamine—Immune system disorder—Etoposide—sarcoma	0.00224	0.0039	CcSEcCtD
Cysteamine—Eye pain—Epirubicin—sarcoma	0.00222	0.00387	CcSEcCtD
Cysteamine—Mental disability—Doxorubicin—sarcoma	0.00222	0.00387	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—JUN—sarcoma	0.0022	0.0122	CbGpPWpGaD
Cysteamine—Discomfort—Mitoxantrone—sarcoma	0.00218	0.0038	CcSEcCtD
Cysteamine—Somnolence—Thiotepa—sarcoma	0.00218	0.00379	CcSEcCtD
Cysteamine—Anaphylactic shock—Vincristine—sarcoma	0.00217	0.00378	CcSEcCtD
Cysteamine—Dyspepsia—Thiotepa—sarcoma	0.00216	0.00376	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.00214	0.00372	CcSEcCtD
Cysteamine—Confusional state—Mitoxantrone—sarcoma	0.00213	0.00371	CcSEcCtD
Cysteamine—Nervous system disorder—Vincristine—sarcoma	0.00213	0.00371	CcSEcCtD
Cysteamine—Decreased appetite—Thiotepa—sarcoma	0.00213	0.00371	CcSEcCtD
Cysteamine—Hepatic function abnormal—Doxorubicin—sarcoma	0.00213	0.0037	CcSEcCtD
Cysteamine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00212	0.00368	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00212	0.00368	CcSEcCtD
Cysteamine—Decreased appetite—Dactinomycin—sarcoma	0.00212	0.00368	CcSEcCtD
Cysteamine—Fatigue—Thiotepa—sarcoma	0.00211	0.00368	CcSEcCtD
Cysteamine—Fatigue—Dactinomycin—sarcoma	0.0021	0.00365	CcSEcCtD
Cysteamine—Constipation—Thiotepa—sarcoma	0.0021	0.00365	CcSEcCtD
Cysteamine—Anorexia—Vincristine—sarcoma	0.00207	0.00361	CcSEcCtD
Cysteamine—Eye pain—Doxorubicin—sarcoma	0.00206	0.00358	CcSEcCtD
Cysteamine—Skin disorder—Mitoxantrone—sarcoma	0.00206	0.00358	CcSEcCtD
Cysteamine—Lethargy—Epirubicin—sarcoma	0.00205	0.00357	CcSEcCtD
Cysteamine—Feeling abnormal—Thiotepa—sarcoma	0.00202	0.00352	CcSEcCtD
Cysteamine—Anorexia—Mitoxantrone—sarcoma	0.00202	0.00351	CcSEcCtD
Cysteamine—Pain in extremity—Epirubicin—sarcoma	0.00201	0.0035	CcSEcCtD
Cysteamine—Feeling abnormal—Dactinomycin—sarcoma	0.00201	0.00349	CcSEcCtD
Cysteamine—Gastrointestinal pain—Thiotepa—sarcoma	0.002	0.00349	CcSEcCtD
Cysteamine—Anaemia—Etoposide—sarcoma	0.00199	0.00347	CcSEcCtD
Cysteamine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00199	0.00346	CcSEcCtD
Cysteamine—Affect lability—Epirubicin—sarcoma	0.00198	0.00344	CcSEcCtD
Cysteamine—Urticaria—Thiotepa—sarcoma	0.00195	0.00339	CcSEcCtD
Cysteamine—Abdominal pain—Thiotepa—sarcoma	0.00194	0.00337	CcSEcCtD
Cysteamine—Body temperature increased—Thiotepa—sarcoma	0.00194	0.00337	CcSEcCtD
Cysteamine—Leukopenia—Etoposide—sarcoma	0.00193	0.00336	CcSEcCtD
Cysteamine—Body temperature increased—Dactinomycin—sarcoma	0.00192	0.00335	CcSEcCtD
Cysteamine—Abdominal pain—Dactinomycin—sarcoma	0.00192	0.00335	CcSEcCtD
Cysteamine—Mood swings—Epirubicin—sarcoma	0.0019	0.00331	CcSEcCtD
Cysteamine—Lethargy—Doxorubicin—sarcoma	0.0019	0.0033	CcSEcCtD
Cysteamine—Decreased appetite—Vincristine—sarcoma	0.00189	0.00329	CcSEcCtD
Cysteamine—Ataxia—Epirubicin—sarcoma	0.00189	0.00329	CcSEcCtD
Cysteamine—Somnolence—Mitoxantrone—sarcoma	0.00188	0.00328	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Vincristine—sarcoma	0.00188	0.00327	CcSEcCtD
Cysteamine—Fatigue—Vincristine—sarcoma	0.00187	0.00326	CcSEcCtD
Cysteamine—Convulsion—Etoposide—sarcoma	0.00187	0.00325	CcSEcCtD
Cysteamine—Dehydration—Epirubicin—sarcoma	0.00187	0.00325	CcSEcCtD
Cysteamine—Dyspepsia—Mitoxantrone—sarcoma	0.00186	0.00324	CcSEcCtD
Cysteamine—Hypertension—Etoposide—sarcoma	0.00186	0.00324	CcSEcCtD
Cysteamine—Constipation—Vincristine—sarcoma	0.00186	0.00323	CcSEcCtD
Cysteamine—Pain in extremity—Doxorubicin—sarcoma	0.00186	0.00323	CcSEcCtD
Cysteamine—Liver function test abnormal—Epirubicin—sarcoma	0.00185	0.00323	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—CCND1—sarcoma	0.00184	0.0102	CbGpPWpGaD
Cysteamine—Decreased appetite—Mitoxantrone—sarcoma	0.00184	0.0032	CcSEcCtD
Cysteamine—Affect lability—Doxorubicin—sarcoma	0.00183	0.00318	CcSEcCtD
Cysteamine—Fatigue—Mitoxantrone—sarcoma	0.00183	0.00318	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00182	0.00317	CcSEcCtD
Cysteamine—Discomfort—Etoposide—sarcoma	0.00181	0.00316	CcSEcCtD
Cysteamine—Constipation—Mitoxantrone—sarcoma	0.00181	0.00315	CcSEcCtD
Cysteamine—Hypersensitivity—Thiotepa—sarcoma	0.00181	0.00314	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCR4—sarcoma	0.0018	0.00994	CbGpPWpGaD
Cysteamine—Hypersensitivity—Dactinomycin—sarcoma	0.00179	0.00312	CcSEcCtD
Cysteamine—Gastrointestinal pain—Vincristine—sarcoma	0.00178	0.00309	CcSEcCtD
Cysteamine—Confusional state—Etoposide—sarcoma	0.00178	0.00309	CcSEcCtD
Cysteamine—Anaphylactic shock—Etoposide—sarcoma	0.00176	0.00306	CcSEcCtD
Cysteamine—Mood swings—Doxorubicin—sarcoma	0.00176	0.00306	CcSEcCtD
Cysteamine—Asthenia—Thiotepa—sarcoma	0.00176	0.00306	CcSEcCtD
Cysteamine—Ataxia—Doxorubicin—sarcoma	0.00175	0.00304	CcSEcCtD
Cysteamine—Asthenia—Dactinomycin—sarcoma	0.00175	0.00304	CcSEcCtD
Cysteamine—Feeling abnormal—Mitoxantrone—sarcoma	0.00174	0.00304	CcSEcCtD
Cysteamine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00173	0.00301	CcSEcCtD
Cysteamine—Dehydration—Doxorubicin—sarcoma	0.00173	0.00301	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCR4—sarcoma	0.00173	0.00953	CbGpPWpGaD
Cysteamine—Body temperature increased—Vincristine—sarcoma	0.00172	0.00299	CcSEcCtD
Cysteamine—Abdominal pain—Vincristine—sarcoma	0.00172	0.00299	CcSEcCtD
Cysteamine—Liver function test abnormal—Doxorubicin—sarcoma	0.00172	0.00299	CcSEcCtD
Cysteamine—Skin disorder—Etoposide—sarcoma	0.00171	0.00298	CcSEcCtD
Cysteamine—Urticaria—Mitoxantrone—sarcoma	0.00168	0.00293	CcSEcCtD
Cysteamine—Anorexia—Etoposide—sarcoma	0.00168	0.00292	CcSEcCtD
Cysteamine—Diarrhoea—Thiotepa—sarcoma	0.00168	0.00292	CcSEcCtD
Cysteamine—Abdominal pain—Mitoxantrone—sarcoma	0.00167	0.00291	CcSEcCtD
Cysteamine—Body temperature increased—Mitoxantrone—sarcoma	0.00167	0.00291	CcSEcCtD
Cysteamine—Diarrhoea—Dactinomycin—sarcoma	0.00166	0.0029	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCR4—sarcoma	0.00164	0.00902	CbGpPWpGaD
Cysteamine—Dizziness—Thiotepa—sarcoma	0.00162	0.00282	CcSEcCtD
Cysteamine—Hypersensitivity—Vincristine—sarcoma	0.0016	0.00279	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—NRAS—sarcoma	0.00159	0.00875	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCR4—sarcoma	0.00157	0.00865	CbGpPWpGaD
Cysteamine—Somnolence—Etoposide—sarcoma	0.00157	0.00272	CcSEcCtD
Cysteamine—Hypersensitivity—Mitoxantrone—sarcoma	0.00156	0.00271	CcSEcCtD
Cysteamine—Asthenia—Vincristine—sarcoma	0.00156	0.00271	CcSEcCtD
Cysteamine—Vomiting—Thiotepa—sarcoma	0.00156	0.00271	CcSEcCtD
Cysteamine—Vomiting—Dactinomycin—sarcoma	0.00155	0.00269	CcSEcCtD
Cysteamine—Rash—Thiotepa—sarcoma	0.00155	0.00269	CcSEcCtD
Cysteamine—Dermatitis—Thiotepa—sarcoma	0.00154	0.00269	CcSEcCtD
Cysteamine—Headache—Thiotepa—sarcoma	0.00154	0.00267	CcSEcCtD
Cysteamine—Rash—Dactinomycin—sarcoma	0.00153	0.00267	CcSEcCtD
Cysteamine—Decreased appetite—Etoposide—sarcoma	0.00153	0.00266	CcSEcCtD
Cysteamine—Renal failure—Epirubicin—sarcoma	0.00152	0.00265	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Etoposide—sarcoma	0.00152	0.00265	CcSEcCtD
Cysteamine—Asthenia—Mitoxantrone—sarcoma	0.00152	0.00264	CcSEcCtD
Cysteamine—Fatigue—Etoposide—sarcoma	0.00152	0.00264	CcSEcCtD
Cysteamine—SST—Signaling Pathways—TLE1—sarcoma	0.00152	0.00837	CbGpPWpGaD
Cysteamine—Constipation—Etoposide—sarcoma	0.00151	0.00262	CcSEcCtD
Cysteamine—Diarrhoea—Vincristine—sarcoma	0.00149	0.00259	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—MYC—sarcoma	0.00148	0.00815	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—sarcoma	0.00147	0.00812	CbGpPWpGaD
Cysteamine—Nausea—Thiotepa—sarcoma	0.00146	0.00253	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TLE1—sarcoma	0.00146	0.00802	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—sarcoma	0.00146	0.00802	CbGpPWpGaD
Cysteamine—Feeling abnormal—Etoposide—sarcoma	0.00145	0.00253	CcSEcCtD
Cysteamine—Diarrhoea—Mitoxantrone—sarcoma	0.00145	0.00252	CcSEcCtD
Cysteamine—Nausea—Dactinomycin—sarcoma	0.00145	0.00251	CcSEcCtD
Cysteamine—Gastrointestinal pain—Etoposide—sarcoma	0.00144	0.00251	CcSEcCtD
Cysteamine—Dizziness—Vincristine—sarcoma	0.00144	0.0025	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—sarcoma	0.00141	0.00245	CcSEcCtD
Cysteamine—Urticaria—Etoposide—sarcoma	0.0014	0.00243	CcSEcCtD
Cysteamine—Abdominal pain—Etoposide—sarcoma	0.00139	0.00242	CcSEcCtD
Cysteamine—Body temperature increased—Etoposide—sarcoma	0.00139	0.00242	CcSEcCtD
Cysteamine—Vomiting—Vincristine—sarcoma	0.00138	0.00241	CcSEcCtD
Cysteamine—Urinary tract disorder—Epirubicin—sarcoma	0.00137	0.00239	CcSEcCtD
Cysteamine—Rash—Vincristine—sarcoma	0.00137	0.00239	CcSEcCtD
Cysteamine—Dermatitis—Vincristine—sarcoma	0.00137	0.00238	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—KRAS—sarcoma	0.00137	0.00753	CbGpPWpGaD
Cysteamine—Connective tissue disorder—Epirubicin—sarcoma	0.00137	0.00238	CcSEcCtD
Cysteamine—Urethral disorder—Epirubicin—sarcoma	0.00136	0.00237	CcSEcCtD
Cysteamine—Headache—Vincristine—sarcoma	0.00136	0.00237	CcSEcCtD
Cysteamine—Vomiting—Mitoxantrone—sarcoma	0.00135	0.00234	CcSEcCtD
Cysteamine—Rash—Mitoxantrone—sarcoma	0.00133	0.00232	CcSEcCtD
Cysteamine—Dermatitis—Mitoxantrone—sarcoma	0.00133	0.00232	CcSEcCtD
Cysteamine—Headache—Mitoxantrone—sarcoma	0.00133	0.00231	CcSEcCtD
Cysteamine—Hypersensitivity—Etoposide—sarcoma	0.0013	0.00226	CcSEcCtD
Cysteamine—Nausea—Vincristine—sarcoma	0.00129	0.00225	CcSEcCtD
Cysteamine—SST—Signaling Pathways—VEGFC—sarcoma	0.00128	0.00706	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Doxorubicin—sarcoma	0.00127	0.00221	CcSEcCtD
Cysteamine—Asthenia—Etoposide—sarcoma	0.00126	0.0022	CcSEcCtD
Cysteamine—Connective tissue disorder—Doxorubicin—sarcoma	0.00126	0.0022	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—sarcoma	0.00126	0.00219	CcSEcCtD
Cysteamine—Nausea—Mitoxantrone—sarcoma	0.00126	0.00219	CcSEcCtD
Cysteamine—Immune system disorder—Epirubicin—sarcoma	0.00125	0.00218	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—VEGFC—sarcoma	0.00123	0.00677	CbGpPWpGaD
Cysteamine—Mental disorder—Epirubicin—sarcoma	0.00122	0.00212	CcSEcCtD
Cysteamine—Erythema—Epirubicin—sarcoma	0.00121	0.0021	CcSEcCtD
Cysteamine—Malnutrition—Epirubicin—sarcoma	0.00121	0.0021	CcSEcCtD
Cysteamine—Diarrhoea—Etoposide—sarcoma	0.0012	0.0021	CcSEcCtD
Cysteamine—Tension—Epirubicin—sarcoma	0.00119	0.00207	CcSEcCtD
Cysteamine—Nervousness—Epirubicin—sarcoma	0.00117	0.00204	CcSEcCtD
Cysteamine—Dizziness—Etoposide—sarcoma	0.00116	0.00203	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—sarcoma	0.00116	0.0064	CbGpPWpGaD
Cysteamine—Immune system disorder—Doxorubicin—sarcoma	0.00116	0.00202	CcSEcCtD
Cysteamine—Mental disorder—Doxorubicin—sarcoma	0.00113	0.00196	CcSEcCtD
Cysteamine—Vomiting—Etoposide—sarcoma	0.00112	0.00195	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—sarcoma	0.00112	0.00195	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—sarcoma	0.00112	0.00195	CcSEcCtD
Cysteamine—Anaemia—Epirubicin—sarcoma	0.00112	0.00195	CcSEcCtD
Cysteamine—Agitation—Epirubicin—sarcoma	0.00111	0.00193	CcSEcCtD
Cysteamine—Rash—Etoposide—sarcoma	0.00111	0.00193	CcSEcCtD
Cysteamine—Dermatitis—Etoposide—sarcoma	0.00111	0.00193	CcSEcCtD
Cysteamine—Headache—Etoposide—sarcoma	0.0011	0.00192	CcSEcCtD
Cysteamine—Tension—Doxorubicin—sarcoma	0.0011	0.00191	CcSEcCtD
Cysteamine—Nervousness—Doxorubicin—sarcoma	0.00109	0.00189	CcSEcCtD
Cysteamine—Leukopenia—Epirubicin—sarcoma	0.00108	0.00188	CcSEcCtD
Cysteamine—Convulsion—Epirubicin—sarcoma	0.00105	0.00182	CcSEcCtD
Cysteamine—Nausea—Etoposide—sarcoma	0.00105	0.00182	CcSEcCtD
Cysteamine—Hypertension—Epirubicin—sarcoma	0.00104	0.00182	CcSEcCtD
Cysteamine—Anaemia—Doxorubicin—sarcoma	0.00103	0.0018	CcSEcCtD
Cysteamine—Agitation—Doxorubicin—sarcoma	0.00103	0.00179	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FLT1—sarcoma	0.00102	0.00564	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00102	0.00178	CcSEcCtD
Cysteamine—Discomfort—Epirubicin—sarcoma	0.00102	0.00177	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PLCG1—sarcoma	0.00101	0.00555	CbGpPWpGaD
Cysteamine—Leukopenia—Doxorubicin—sarcoma	0.001	0.00174	CcSEcCtD
Cysteamine—Confusional state—Epirubicin—sarcoma	0.000995	0.00173	CcSEcCtD
Cysteamine—Anaphylactic shock—Epirubicin—sarcoma	0.000987	0.00172	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FLT1—sarcoma	0.000982	0.00541	CbGpPWpGaD
Cysteamine—Convulsion—Doxorubicin—sarcoma	0.00097	0.00169	CcSEcCtD
Cysteamine—Nervous system disorder—Epirubicin—sarcoma	0.000968	0.00168	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCR4—sarcoma	0.000967	0.00533	CbGpPWpGaD
Cysteamine—Hypertension—Doxorubicin—sarcoma	0.000966	0.00168	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PLCG1—sarcoma	0.000965	0.00532	CbGpPWpGaD
Cysteamine—Skin disorder—Epirubicin—sarcoma	0.000959	0.00167	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ATF1—sarcoma	0.000956	0.00527	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000946	0.00165	CcSEcCtD
Cysteamine—Discomfort—Doxorubicin—sarcoma	0.000941	0.00164	CcSEcCtD
Cysteamine—Anorexia—Epirubicin—sarcoma	0.000941	0.00164	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCR4—sarcoma	0.000927	0.00511	CbGpPWpGaD
Cysteamine—Confusional state—Doxorubicin—sarcoma	0.000921	0.0016	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ATF1—sarcoma	0.000917	0.00505	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Doxorubicin—sarcoma	0.000913	0.00159	CcSEcCtD
Cysteamine—Nervous system disorder—Doxorubicin—sarcoma	0.000896	0.00156	CcSEcCtD
Cysteamine—Skin disorder—Doxorubicin—sarcoma	0.000887	0.00154	CcSEcCtD
Cysteamine—Somnolence—Epirubicin—sarcoma	0.000878	0.00153	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CREB1—sarcoma	0.000877	0.00483	CbGpPWpGaD
Cysteamine—Anorexia—Doxorubicin—sarcoma	0.000871	0.00152	CcSEcCtD
Cysteamine—Dyspepsia—Epirubicin—sarcoma	0.000869	0.00151	CcSEcCtD
Cysteamine—Decreased appetite—Epirubicin—sarcoma	0.000858	0.00149	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000852	0.00148	CcSEcCtD
Cysteamine—Fatigue—Epirubicin—sarcoma	0.000851	0.00148	CcSEcCtD
Cysteamine—Constipation—Epirubicin—sarcoma	0.000844	0.00147	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CREB1—sarcoma	0.000841	0.00463	CbGpPWpGaD
Cysteamine—Feeling abnormal—Epirubicin—sarcoma	0.000813	0.00142	CcSEcCtD
Cysteamine—Somnolence—Doxorubicin—sarcoma	0.000812	0.00141	CcSEcCtD
Cysteamine—Gastrointestinal pain—Epirubicin—sarcoma	0.000807	0.0014	CcSEcCtD
Cysteamine—Dyspepsia—Doxorubicin—sarcoma	0.000804	0.0014	CcSEcCtD
Cysteamine—Decreased appetite—Doxorubicin—sarcoma	0.000794	0.00138	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000789	0.00137	CcSEcCtD
Cysteamine—Fatigue—Doxorubicin—sarcoma	0.000787	0.00137	CcSEcCtD
Cysteamine—Urticaria—Epirubicin—sarcoma	0.000784	0.00136	CcSEcCtD
Cysteamine—Constipation—Doxorubicin—sarcoma	0.000781	0.00136	CcSEcCtD
Cysteamine—Body temperature increased—Epirubicin—sarcoma	0.00078	0.00136	CcSEcCtD
Cysteamine—Abdominal pain—Epirubicin—sarcoma	0.00078	0.00136	CcSEcCtD
Cysteamine—Feeling abnormal—Doxorubicin—sarcoma	0.000753	0.00131	CcSEcCtD
Cysteamine—SST—Signaling Pathways—IGF1R—sarcoma	0.00075	0.00414	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000747	0.0013	CcSEcCtD
Cysteamine—Hypersensitivity—Epirubicin—sarcoma	0.000727	0.00127	CcSEcCtD
Cysteamine—Urticaria—Doxorubicin—sarcoma	0.000726	0.00126	CcSEcCtD
Cysteamine—Body temperature increased—Doxorubicin—sarcoma	0.000722	0.00126	CcSEcCtD
Cysteamine—Abdominal pain—Doxorubicin—sarcoma	0.000722	0.00126	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—IGF1R—sarcoma	0.000719	0.00396	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FOXO1—sarcoma	0.000714	0.00394	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL2—sarcoma	0.000714	0.00393	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDGFRB—sarcoma	0.000713	0.00393	CbGpPWpGaD
Cysteamine—Asthenia—Epirubicin—sarcoma	0.000708	0.00123	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PDGFRA—sarcoma	0.000702	0.00387	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FOXO1—sarcoma	0.000685	0.00377	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—sarcoma	0.000684	0.00377	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PDGFRB—sarcoma	0.000683	0.00377	CbGpPWpGaD
Cysteamine—Diarrhoea—Epirubicin—sarcoma	0.000675	0.00118	CcSEcCtD
Cysteamine—Hypersensitivity—Doxorubicin—sarcoma	0.000673	0.00117	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PDGFRA—sarcoma	0.000673	0.00371	CbGpPWpGaD
Cysteamine—Asthenia—Doxorubicin—sarcoma	0.000655	0.00114	CcSEcCtD
Cysteamine—Dizziness—Epirubicin—sarcoma	0.000653	0.00114	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL2—sarcoma	0.000648	0.00357	CbGpPWpGaD
Cysteamine—Vomiting—Epirubicin—sarcoma	0.000628	0.00109	CcSEcCtD
Cysteamine—Diarrhoea—Doxorubicin—sarcoma	0.000625	0.00109	CcSEcCtD
Cysteamine—Rash—Epirubicin—sarcoma	0.000622	0.00108	CcSEcCtD
Cysteamine—Dermatitis—Epirubicin—sarcoma	0.000622	0.00108	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL2—sarcoma	0.000621	0.00343	CbGpPWpGaD
Cysteamine—Headache—Epirubicin—sarcoma	0.000618	0.00108	CcSEcCtD
Cysteamine—Dizziness—Doxorubicin—sarcoma	0.000604	0.00105	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KDR—sarcoma	0.000591	0.00326	CbGpPWpGaD
Cysteamine—Nausea—Epirubicin—sarcoma	0.000586	0.00102	CcSEcCtD
Cysteamine—Vomiting—Doxorubicin—sarcoma	0.000581	0.00101	CcSEcCtD
Cysteamine—Rash—Doxorubicin—sarcoma	0.000576	0.001	CcSEcCtD
Cysteamine—Dermatitis—Doxorubicin—sarcoma	0.000575	0.001	CcSEcCtD
Cysteamine—Headache—Doxorubicin—sarcoma	0.000572	0.000996	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KDR—sarcoma	0.000566	0.00312	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KIT—sarcoma	0.000544	0.003	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NRAS—sarcoma	0.000544	0.003	CbGpPWpGaD
Cysteamine—Nausea—Doxorubicin—sarcoma	0.000543	0.000944	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KIT—sarcoma	0.000522	0.00288	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NRAS—sarcoma	0.000522	0.00288	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CREB1—sarcoma	0.000518	0.00286	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CREB1—sarcoma	0.000497	0.00274	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—sarcoma	0.000496	0.00273	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—sarcoma	0.000475	0.00262	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KRAS—sarcoma	0.000468	0.00258	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—sarcoma	0.000449	0.00247	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MDM2—sarcoma	0.000428	0.00236	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MDM2—sarcoma	0.000411	0.00226	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—sarcoma	0.000398	0.00219	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—sarcoma	0.000383	0.00211	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—sarcoma	0.000382	0.0021	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—sarcoma	0.000373	0.00206	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JUN—sarcoma	0.000372	0.00205	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CTNNB1—sarcoma	0.00037	0.00204	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—sarcoma	0.000367	0.00202	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCND1—sarcoma	0.000358	0.00197	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JUN—sarcoma	0.000357	0.00197	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CTNNB1—sarcoma	0.000354	0.00195	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SRC—sarcoma	0.000334	0.00184	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—sarcoma	0.000325	0.00179	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NRAS—sarcoma	0.000321	0.00177	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SRC—sarcoma	0.00032	0.00177	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—sarcoma	0.000312	0.00172	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NRAS—sarcoma	0.000308	0.0017	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—sarcoma	0.000299	0.00165	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—sarcoma	0.000293	0.00161	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—sarcoma	0.000287	0.00158	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—sarcoma	0.000281	0.00155	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—sarcoma	0.000277	0.00152	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—sarcoma	0.000265	0.00146	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—sarcoma	0.000246	0.00136	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—sarcoma	0.000236	0.0013	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—sarcoma	0.000235	0.0013	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—sarcoma	0.000225	0.00124	CbGpPWpGaD
